Obefazimod — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active
Phase 2 · Moderately to Severely Active Crohn Disease |
ABVX Abivax S.A. | Obefazimod |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|